Medibank Private (MPL.AX) Stock Price
Medibank Private Price
Revenue has compounded at 5.8% per year over the past 19 years to 9.33 B AUD. Earnings per share have grown at 8.1% per year over the last 13 years. Medibank Private's net margin stands at 6.8%, up from 5.6% several years earlier. Medibank Private currently offers a dividend yield of about 2.56%. The payout ratio is around 129% of earnings. The dividend has grown at 4.2% per year over the past 11 years. Analysts set a median price target of 5.00 AUD, implying 7.7% above the current price. Of 14 analysts, 5 rate the stock a buy — an overall Hold consensus.
Medibank Private stock price
Medibank Private business model & stock analysis
Frequently asked questions about Medibank Private
Medibank Private Ltd operates as a leading private health insurance provider in Australia. The company's business model revolves around offering health insurance products and services to a wide range of individuals and families. Medibank Private aims to ensure accessibility, affordability, and quality healthcare for its customers. The company's model focuses on providing comprehensive coverage, including hospital treatment, specialist consultations, and ancillary services. By leveraging its extensive network of healthcare providers and utilizing advanced technological solutions, Medibank Private delivers value-based and customer-centric healthcare solutions. With a strong emphasis on innovation and customer satisfaction, Medibank Private continues to serve as a reliable and trusted health insurance partner.
Medibank Private Ltd is primarily active in the healthcare industry.
The main competitors of Medibank Private Ltd in the market include Bupa Australia, HCF, NIB Holdings Ltd, and HBF Health Limited.
Medibank Private Ltd is an Australian private health insurance company. It was established in 1976 as a government-owned entity to provide affordable health coverage to Australians. Initially, it operated as a not-for-profit organization until it was privatized in 2014 and listed on the Australian Securities Exchange (ASX). Since then, Medibank has evolved into a leading health insurer, offering a wide range of health insurance products and services to individuals, families, and businesses across Australia. With a strong focus on customer satisfaction and innovative healthcare solutions, Medibank Private Ltd continues to play a vital role in ensuring the well-being of millions of Australians.
Medibank Private Ltd, Australia's leading health insurer, has achieved several significant milestones throughout its history. One of the key achievements was its successful initial public offering (IPO) in 2014, marking its transition from a government-owned entity to a publicly listed company. Since then, Medibank has consistently delivered strong financial performance, demonstrating its commitment to shareholder value. The company has also expanded its services by introducing innovative healthcare programs and partnerships, aimed at improving the health and well-being of its members. Medibank's focus on customer satisfaction and high-quality healthcare has enabled it to become a trusted name in the industry, further reinforcing its position as a market leader.
Medibank Private Ltd is primarily present in Australia. This leading private health insurance provider operates predominantly in its home country, catering to a wide customer base. With its headquarters located in Melbourne, Medibank Private Ltd offers a range of health insurance services and products to individuals, families, and businesses across Australia.
Medibank Private Ltd represents a commitment to delivering high-quality healthcare services to its customers. The company values customer satisfaction and aims to provide accessible and affordable healthcare for all Australians. Medibank Private Ltd places importance on innovation, investing in new technologies and approaches to improve healthcare outcomes. With a focus on corporate responsibility, the company aims to make a positive impact on the health and wellbeing of individuals and communities. Medibank Private Ltd strives to be a trusted and customer-centric healthcare provider, ensuring the utmost care and support for its customers' health needs.
Analysts currently set an average price target of 5.22 AUD for the Medibank Private stock (median: 5.00 AUD), implying +12.4 % versus the latest price. The consensus is based on 14 analyst ratings.
14 analysts currently rate the Medibank Private stock: 5 recommend buying, 9 holding and 0 selling.
Converted at the current exchange rate, the Medibank Private share trades at 2.88 EUR (4.64 AUD).
The Medibank Private share (MPL.AX) is listed on 5 stock exchanges, including: SIX (Zürich) (MPV.SW), ASX (MPL.AX), Frankfurt (MPV.F), München (MPV.MU), Düsseldorf (MPV.DU).
Medibank Private Ltd is a leading Australian health insurance company that provides its customers with high-quality health solutions and medical services. The company operates in four main areas: health insurance, health services, private hospitals, and life insurance. It offers a wide range of health insurance products and services, including individual and family plans, group plans for businesses, and a variety of health services such as home visits, telemedicine, and emergency services. The private hospital division provides access to top-notch facilities and medical services. The company also offers life insurance products and services, including life insurance, income protection insurance, and accident insurance. Medibank Private aims to improve the customer experience through innovative technologies and digital services, offering tools and applications to manage and improve health and lifestyle. Overall, Medibank Private has a strong business model focused on providing high-quality health solutions and medical services, with a strong market position and a commitment to expanding its product and service offerings to meet the changing needs of its customers.
The revenue of Medibank Private is 9.33 B AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Medibank Private is 638.70 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Medibank Private is currently 20.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medibank Private stock.
The price-to-sales ratio (P/S) of Medibank Private is currently 1.37. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medibank Private stock.
The Eulerpool Quality Score for Medibank Private is 5/10.
The ISIN of Medibank Private is AU000000MPL3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Medibank Private is A12D1W. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Medibank Private is MPL.AX. The ticker symbol is used to trade Medibank Private shares on the stock exchange.
Medibank Private stock
Medibank Private Peer Group
Medibank Private Ticker
Medibank Private FIGI
All fundamentals and in-depth analysis of Medibank Private
Our stock analysis for Medibank Private stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medibank Private. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.